Skip to main content
Clinical Trials/NCT01320475
NCT01320475
Terminated
Phase 4

Thoracic Epidural Analgesia: Epidural Levobupivacaine and Sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine

Hopital Foch1 site in 1 country2 target enrollmentSeptember 2010

Overview

Phase
Phase 4
Intervention
Ketamine
Conditions
Thoracic Surgery
Sponsor
Hopital Foch
Enrollment
2
Locations
1
Primary Endpoint
Efficacy of the analgesic regimen
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

Thoracic epidural analgesia is often proposed to thoracotomized patients. A local anesthetic and an opioid are generally associated to produce an epidural analgesia. However, opioid epidural administration is frequently associated with adverse effects as nausea, vomiting, urinary retention, ... On the other hand, iv ketamine has been demonstrated to be an effective analgesic.

The purpose of the study is to compare the epidural administration of levobupivacaine and sufentanil or the epidural administration of levobupivacaine associated with the iv administration of ketamine.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
July 2011
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age between 18 and 75 yrs
  • class ASA I, II or III
  • lung surgery

Exclusion Criteria

  • Contra-indication to the achievement of epidural analgesia
  • Preoperative chronic pain,
  • Contra-indication to ketamine
  • Hypersensitivity to ketamine or any excipients
  • Uncontrolled hypertension,
  • Heart failure
  • Hepatic porphyria
  • Contra-indication to sufentanil
  • Hypersensitivity to sufentanil, opioids or any excipients
  • Treatment with an opioid agonist-antagonist,

Arms & Interventions

iv Ketamine

Epidural infusion of levobupivacaine and saline (placebo for sufentanil)and iv infusion of ketamine Up to the third postoperative day (6 PM)

Intervention: Ketamine

Sufentanil

Epidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)

Intervention: Sufentanil

Outcomes

Primary Outcomes

Efficacy of the analgesic regimen

Time Frame: third postoperative day

Occurrence of an adverse event due to the analgesic protocol

Time Frame: one week

Secondary Outcomes

  • postoperative complications (pulmonary, others)(one month)
  • length of stay(one month)
  • patient's satisfaction(sortie de l'hopital)
  • Occurence of a chronic pain(end the first postoperative year)
  • postoperative rehabilitation(two weeks)

Study Sites (1)

Loading locations...

Similar Trials